Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques.

Urology

Volumn 54, Issue 6, 1999, Pages 968-971

  Critz, F A ^a   Williams, W H ^a   Holladay, C T ^a   Levinson, A K ^a   Benton, J B ^a   Holladay, D A ^a   Schnell Jr , F J ^a   Maxa, L S ^a   Shrake, P D ^a  

^a Radiotherapy Clinics of Georgia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; REMISSION;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REMISSION INDUCTION;

MLCS; MLOWN;

EID: 0033253970     PISSN: None     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/s0090-4295(99)00346-5     Document Type: Article

References (0)